Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Galapagos NV ADR (GLPG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Galapagos ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
28.91 -0.31    -1.06%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
28.91
0.00
0.00%
16:01:53 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 139,107
  • Bid/Ask: 28.00 / 29.80
  • Day's Range: 28.82 - 29.20
Galapagos ADR 28.91 -0.31 -1.06%

GLPG Income Statement

 
Featured here, the Income Statement (earnings report) for Galapagos NV ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue - 120.03 149.95 178.87
Revenue - 120.03 149.95 178.87
Other Revenue, Total - - - -
Cost of Revenue, Total - 317.88 -99.25 107.09
Gross Profit - -197.85 249.21 71.77
Total Operating Expenses - 150.26 160.64 156.9
Selling/General/Admin. Expenses, Total - 60.57 63.49 58.1
Research & Development - -211.88 211.88 103.52
Depreciation / Amortization - -18.57 18.57 -
Interest Expense (Income) - Net Operating - -4.14 -0.624 -2.17
Unusual Expense (Income) - - - -
Other Operating Expenses, Total - 6.39 -33.41 -111.82
Operating Income - -30.23 -10.69 21.97
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - 20.97 12.73 -
Other, Net - -76.93 -41.88 -1.49
Net Income Before Taxes - 25.73 18.46 23.46
Provision for Income Taxes - -0.1 13.36 0.254
Net Income After Taxes - 25.83 5.1 23.21
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items - 25.83 5.1 23.21
Total Extraordinary Items - - - -
Net Income - 25.83 5.1 23.21
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items - 25.83 5.1 23.21
Dilution Adjustment - - - -
Diluted Net Income - 25.83 5.1 23.21
Diluted Weighted Average Shares - 66.27 65.49 66.31
Diluted EPS Excluding Extraordinary Items - 0.39 0.078 0.35
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS - 0.045 0.055 0.221
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GLPG Comments

Write your thoughts about Galapagos NV ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rahmi Pidie
Rahmi Pidie Apr 03, 2022 6:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell
Bart Van Der Zanden
Bart Van Der Zanden Apr 26, 2021 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy now?
Maya Normusbut
Maya Normusbut Feb 11, 2021 8:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they have 5 bil in cash. Cashburn should be -10% annually. + sales filgotinib + pipeline speculations + new aquired businesses (they are looking to take over other companies with revenu)  . i think this is way oversold.
Eren Eren
Eren Eren Feb 11, 2021 8:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Look where we are now.... what do you think 🤪
Dümaine Hinds
Kingshad Feb 11, 2021 4:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long-term head and shoulder pattern
Tomer Brosh
Tomer Brosh Feb 10, 2021 5:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dead?
Commodity Trader
Commodity Trader Feb 10, 2021 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GALAPAGOS is what we will see for all the markets soon, maybe end 21 but it will all come down
Job Losm
Job Losm Feb 10, 2021 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whats's your prediction?
Lars Holland
Lars Holland Oct 30, 2020 5:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Galapagos Enters November With Flair: New Revelation About Toledo Target Family https://pennystocks.news/galapagos-enters-november-with-flair-new-revelation-about-toledo-target-family-glpg/
mollow itz
mollow itz Jul 24, 2020 9:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.gilead.com/news-and-press/press-room/press-releases/2020/7/gilead-and-galapagos-announce-positive-european-chmp-opinion-for-jyseleca-filgotinib-for-the-treatment-of-adults-with-moderate-to-severe-rheumatoid
Paul Verh
Paul Verh May 24, 2020 5:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Investor overreaction though. Besides, the main application of Filgotinib is not for ulcerative colitis (turnover approximately EUR 500 million) but for rheumatism (turnover EUR 5 BILLION). Great starting moment now.
Maurice Fortune
Maurice Fortune Sep 10, 2019 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What does galapagos do?
Rudi Lenie
Rudi Lenie Sep 10, 2019 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no google in your country?
Coffee Man
Coffee Man Sep 10, 2019 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rudi Lenie  Google so hard... Investing.com so easy to get answer. Me no need to think
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email